Adherence and motility characteristics of clinical Acinetobacter baumannii isolates

被引:121
|
作者
Eijkelkamp, Bart A. [1 ]
Stroeher, Uwe H. [1 ]
Hassan, Karl A. [2 ]
Papadimitrious, Michael S. [1 ]
Paulsen, Ian T. [2 ]
Brown, Melissa H. [1 ]
机构
[1] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia
[2] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia
基金
英国医学研究理事会;
关键词
twitching; swarming; eukaryotic cell adherence; biofilm formation; type IV pili; Australian clinical strains; TWITCHING MOTILITY; EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; XYLELLA-FASTIDIOSA; BIOFILM FORMATION; ABIOTIC SURFACES; RESISTANCE; PATHOGEN; SEQUENCE; PILI;
D O I
10.1111/j.1574-6968.2011.02362.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Acinetobacter baumannii continues to be a major health problem especially in hospital settings. Herein, features that may play a role in persistence and disease potential were investigated in a collection of clinical A. baumannii strains from Australia. Twitching motility was found to be a common trait in A. baumannii international clone I strains and in abundant biofilm formers, whereas swarming motility was only observed in isolates not classified within the international clone lineages. Bioinformatic analysis of the type IV fimbriae revealed a correlation between PilA sequence homology and motility. A high level of variability in adherence to both abiotic surfaces and epithelial cells was found. We report for the first time the motility characteristics of a large number of A. baumannii isolates and present a direct comparison of A. baumannii binding to nasopharyngeal and lung epithelial cells.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 50 条
  • [1] Biofilm Formation and Motility Depend on the nature of the Acinetobacter baumannii clinical isolates
    Vijayakumar, Saranya
    Rajenderan, Sangeetha
    Laishram, Shakti
    Anandan, Shalini
    Balaji, Veeraraghavan
    Biswas, Indranil
    FRONTIERS IN PUBLIC HEALTH, 2016, 4
  • [2] CHARACTERISTICS OF ANTIBIOTIC SENSITIVITY OF ACINETOBACTER BAUMANNII bv. TRYPTOPHANDESTRUENS AND ACINETOBACTER BAUMANNII CLINICAL ISOLATES
    Sivolodskii, E. P.
    Kraeva, L. A.
    Melnicova, E. V.
    Gorelova, G. V.
    INFEKTSIYA I IMMUNITET, 2024, 14 (01): : 170 - 174
  • [3] Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii
    Li, Zhaoyinqian
    Ding, Zixuan
    Liu, Yao
    Jin, Xinrui
    Xie, Jingling
    Li, Tingting
    Zeng, Zhangrui
    Wang, Zhibin
    Liu, Jinbo
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 2613 - 2624
  • [4] An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation
    Mea, Hing Jian
    Yong, Phelim Voon Chen
    Wong, Eng Hwa
    MICROBIOLOGICAL RESEARCH, 2021, 247
  • [5] Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii
    Shi, ZY
    Liu, PYF
    Lau, YJ
    Lin, YH
    Hu, BS
    Shir, JM
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 24 (02) : 81 - 85
  • [6] Triclosan resistance in clinical isolates of Acinetobacter baumannii
    Chen, Yagang
    Pi, Borui
    Zhou, Hua
    Yu, Yunsong
    Li, Lanjuan
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (08) : 1086 - 1091
  • [7] Persister formation in Acinetobacter baumannii clinical isolates
    Baek, M. S.
    Chung, E. S.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S158 - S158
  • [8] Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps
    Sato, Yoshinori
    Unno, Yuka
    Kawakami, Sayoko
    Ubagai, Tsuneyuki
    Ono, Yasuo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (02) : 203 - 212
  • [9] Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
    Lindgren, Patricia Komp
    Higgins, Paul G.
    Seifert, Harald
    Cars, Otto
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 661 - 665
  • [10] Aminoglycoside Resistance Genes in Acinetobacter Baumannii Clinical Isolates
    Rizk, Mohamed A.
    Abou El-Khier, Noha T.
    CLINICAL LABORATORY, 2019, 65 (07) : 1285 - 1291